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The concept that cellular terminal differentiation is stably maintained once development
is complete has been questioned by numerous observations showing that differentiated ep-
ithelium may undergo an epithelial-to-mesenchymal transition (EMT) program. EMTand
the reverse process, mesenchymal-to-epithelial transition (MET), are typical events of de-
velopment, tissue repair, and tumor progression. In this study, we aimed to clarify the mo-
lecular mechanisms underlying these phenotypic conversions in hepatocytes. Hepatocyte
nuclear factor 4a (HNF4a) was overexpressed in different hepatocyte cell lines and the
resulting gene expression profile was determined by real-time quantitative polymerase
chain reaction. HNF4a recruitment on promoters of both mesenchymal and EMT regula-
tor genes was determined by way of electrophoretic mobility shift assay and chromatin
immunoprecipitation. The effect of HNF4a depletion was assessed in silenced cells and in
the context of the whole liver of HNF4 knockout animals. Our results identified key EMT
regulators and mesenchymal genes as new targets of HNF4a. HNF4a, in cooperation with
its target HNF1a, directly inhibits transcription of the EMTmaster regulatory genes Snail,
Slug, and HMGA2 and of several mesenchymal markers. HNF4a-mediated repression of
EMT genes induces MET in hepatomas, and its silencing triggers the mesenchymal pro-
gram in differentiated hepatocytes both in cell culture and in the whole liver. Conclusion:
The pivotal role of HNF4a in the induction and maintenance of hepatocyte differentiation
should also be ascribed to its capacity to continuously repress the mesenchymal program;
thus, both HNF4a activator and repressor functions are necessary for the identity of hepa-
tocytes. (HEPATOLOGY 2011;53:2063-2074)
E
pithelial-to-mesenchymal transition (EMT) is
the process by which polarized cells of the
epithelium lose cell–cell connections and ac-
quire the mesenchymal characteristics of motility and
invasiveness. The reverse process, mesenchymal-to-epi-
thelial transition (MET), often occurs at a site second-
ary to the original EMT population. The dynamic
EMT/MET processes are essential for embryonic de-
velopment and wound repair and initiate the patholog-
ical states of fibrosis and metastatic cancer.1
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transcription-quantitative polymerase chain reaction; siRNA, small interfering RNA; TGFb, transforming growth factor b.
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Several master regulators of EMT have been identi-
fied. The transcriptional repressors of the Snail family,
Snail (Snai1) and Slug (Snai2), induce EMT partly
through direct inhibition of E-cadherin gene transcrip-
tion.2,3 Snail also acts as a point of signal integration
for many other inducers of EMT, including Wnt,
transforming growth factor b (TGFb), Notch, and
estrogens.4 It is generally assumed that completion of
MET involves reverse sequential modulation of the
mechanisms that led to EMT, thereby permitting reac-
quisition of the epithelial phenotype; however, the mo-
lecular mechanisms driving MET are largely unknown.
In the liver, EMT/METs have been postulated for
several terminally differentiated cell types including
parenchymal cells.5 Concerning hepatocytes, whereas
there are solid experimental data supporting EMT
occurrence in culture6-8 and in vivo,9 evidence of
MET remains elusive.
It has been shown that the orphan nuclear receptor
hepatocyte nuclear factor 4a (HNF4a) orchestrates the
expression of several epithelial markers in hepato-
cytes.10 HNF4a confers to fibroblasts an epithelial-like
morphology11 and re-establishes a differentiated phe-
notype to invasive hepatocellular carcinoma.12 These
findings, together with our previous observations
showing that HNF4a counteracts Snail-dependent
down-regulation of epithelial markers,6 suggest that
HNF4a may act as an MET-inducing factor in hepa-
tocytes. Recently, an HNF4a-mediated EMT suppres-
sion was observed in an in vivo model of hepatic fibro-
sis.13 However, the molecular mechanisms allowing
HNF4a to induce MET and to maintain the differen-
tiated liver epithelium have not been fully explored.
In this study, we provide evidence on the molecular
mechanisms by which HNF4a, inducing MET, main-
tains the hepatocyte-differentiated phenotype. Our
data revealed that this role of HNF4a is intrinsically
linked to active repression of the mesenchymal pro-
gram expression. In undifferentiated human and mu-
rine hepatoma cells, HNF4a overexpression correlated
with down-regulation of mesenchymal markers. Tran-
scriptional analysis and chromatin immunoprecipita-
tion (ChIP) assays lead us to identify as direct targets
of HNF4a repression the master regulators of the
EMT program Snail, Slug, and HMGA2. A stable
binding of HNF4a on regulatory sequences of mesen-
chymal genes was found in differentiated hepatocytes
while experimentally induced EMT/MET oscillations
correlate with its dynamic recruitment. Notably, the
relevance of HNF4a in the active repression of mesen-
chymal genes was confirmed in vivo. The mesenchymal
markers vimentin, desmin, and a-smooth muscle actin
were identified in histological samples from mice with
hepatocyte-specific deletion of Hnf4a.14 Our data
highlight the role of HNF4a in controlling the hepatic
epithelial phenotype by repression of master EMT reg-
ulators and mesenchymal genes.
Materials and Methods
Cell Culture Conditions. BW1J and Hep3B cells
were grown as reported in the Supporting Methods.
RNA Extraction, Reverse-Transcription, and
RT-qPCR. Total RNA extraction and real-time quanti-
tative polymerase chain reaction (qPCR) were per-
formed as reported in the Supporting Methods. RT-
qPCR primer sequences are listed in Supporting Tables
2 and 3.
Immunofluorescence and Immunohistochemistry. For
immunofluorescence/immunohistochemistry analysis,
cells and liver slices were treated as reported in the
Supporting Methods.
Bioinformatic Analysis of Promoters. Regulatory
sequences (up to 2 kb upstream of transcription start
site) were obtained from ENSEMBL (http://www.en-
sembl.org) and submitted to MatInspector Professional
(release 8.0, Genomatix, Munchen, Germany) and
cREMaG (http:www.cremag.org) to identify putative
HNFs consensus sites. A transcription factor matrix
symmetry score value >0.84 was accepted as the cutoff
for further analysis by way of electrophoretic mobility
shift assay (EMSA) and ChIP assays.
Statistical Analysis. Statistical analysis was conducted
using the Student t test. All the tests were two-sided, and P
< 0.05 was considered statistically significant.
EMSA. Nuclear protein extraction and EMSA were
performed as reported6 and as described in the Sup-
porting Methods. Probe sequences are reported in Sup-
porting Table 1.
ChIP Assay. ChIP assays in cultured cells and in
liver samples were performed as reported15 and described
in the Supporting Methods.
RNA Interference. MMH D3 cells were transfected
with small interfering RNA (siRNA) oligonucleotides
against HNF4a, or LaminA/C (50-GGUGGUGAC-
GAUCUGGGCUUUTT-30) using ON-TARGET plus
SMARTpool siRNA (J-065463-05/06/07/08; Dharma-
con, Lafayette, CO) by Lipofectamine 2000 (Invitro-
gen, San Diego, CA). RNA and protein were harvested
after 48 hours.
Results
Ectopic HNF4a Induces MET in Hepatoma
Cells. It has been reported that HNF4a promotes the
2064 SANTANGELO ET AL. HEPATOLOGY, June 2011
expression of epithelial markers and liver products in
dedifferentiated hepatoma cells.16 Considering the dual
role of this factor as both a transcriptional activator
and repressor, we aimed to assess whether the molecu-
lar mechanisms by which HNF4a drives the epithelial
differentiation include the down-regulation of mesen-
chymal genes. To address this question, we used the
murine hepatoma cell line BW1J that lacks endoge-
nous expression of HNF4a and displays mesenchymal-
like morphology and invasive behavior.17 Retrovirus-
mediated overexpression of HNF4a induced BW1J
cells (BW-H4) to acquire a cuboidal, tightly packed
hepatocyte-like morphology and to reduce motility
and invasivity (Supporting Fig. 1).
As expected, ectopic HNF4a up-regulated the expres-
sion of the liver-specific genes transthyretin (TTR), albu-
min (Alb), and hepatocyte nuclear factor 1a (Hnf1a)
and the epithelial markers E-cadherin (Cdh1) and cyto-
keratin 18 (Krt18). Notably, BW-H4 cells also showed
the down-regulation of the dedifferentiation marker a-
fetoprotein (aFP); the mesenchymal genes N-cadherin
(Cdh2), a-smooth muscle actin (Acta2), vimentin (Vim),
and fibronectin (Fn1); and the invasivity marker metal-
loproteinase 9 (Mmp9) (Fig. 1A). Similar results were
obtained in human hepatoma Hep3B cells overexpress-
ing HNF4a (3B-H4) (Supporting Fig. 1). Overall, these
data indicate that HNF4a plays a role in MET regula-
tion by modulating epithelial differentiation and mesen-
chymal gene expression.
HNF4a Directly Inhibits the EMT Master Gene
Snail. Because of the complexity in morphological
changes observed in HNF4a-overexpressing hepatoma,
we hypothesized a general EMT repressor role for
HNF4a. Therefore, our analysis focused on known
EMT master regulators. First, we considered the tran-
scriptional repressor Snail, a key EMT inducer in sev-
eral epithelial cell types,18,19 including hepatocytes.6 In
BW-H4 cells, HNF4a ectopic expression caused a sig-
nificant down-regulation of endogenous Snail mRNA
and protein levels (Fig. 1B). Similar data were
obtained in 3B-H4 cells (Supporting Fig. 2).
Bioinformatics analysis of both mouse and human
Snail promoters revealed the presence of two putative
HNF4a binding sites (depicted in Fig. 1E and
Supporting Fig. 2). To test the hypothesis of a direct
transcriptional repression, we first analyzed in BW1J
cells whether HNF4a modulated the activity of a
mouse Snail promoter fused to a luciferase reporter.
This assay showed that Snail promoter activity was
repressed by HNF4a in a dose-dependent manner
(Fig. 1C). A Snail promoter mutated in both HNF4a
consensus sites was used as control.
Next, we tested the ability of HNF4a in vitro to
bind the identified consensus sequences by means of
EMSA. As shown in Fig. 1D, indicated mouse Snail
probes were shifted by nuclear extracts from BW-H4
cells (lane 2 in both panels) and supershifted by anti-
HNF4a antibody (lane 3) but not by control anti-
tubulin antibody (lane 4), thus demonstrating the
presence of a specific binding site for HNF4a on the
mouse Snail promoter. An excess of wild-type, but not
of the mutated cold probe, faded the shift (lanes 5, 6),
whereas the same nuclear extracts failed to shift the la-
beled mutated probes (lanes 8-10). Similar results were
obtained on the human Snail promoter in 3B-H4 cells
(Supporting Fig. 2).
Finally, in order to verify the HNF4a recruitment
to the Snail promoter in vivo, we performed ChIP
experiments with nuclear extracts from differentiated
hepatocytes (MMH-D3), which express HNF4a at a
level comparable with those found in adult liver.20
HNF4a was recruited to both consensus sites on the
Snail promoter together with the nuclear receptor cor-
epressor NCoR (Fig.1E). This result correlates HNF4a
binding on the Snail promoter to the transcriptional
inactivation of the Snail gene. Similar results were
obtained by analyzing the human Snail promoter in
3B-H4 cells (Supporting Fig. 2). These data demon-
strate that Snail is a direct target of HNF4a transcrip-
tional repression activity.
HNF1a Cooperates with HNF4a to Suppress Snail
Expression. We next investigated the potential involve-
ment of HNF1a, another transcription factor pivotal
in hepatocyte differentiation, in the induction of
MET. The rationale for our investigation was based on
the following considerations: (1) HNF1a is an
HNF4a target gene21; (2) the comparative bioinfor-
matic analysis of murine and human Snail promoters
revealed HNF1a consensus sequences in the proximity
of HNF4a binding sites; and (3) HNF1a and HNF4a
physically22 and functionally23 interact to cooperatively
regulate a large fraction of liver transcriptome.24
Notably, ectopic HNF1a caused a significant
decrease in Snail mRNA levels in both murine and
human hepatoma (Fig. 2A). Moreover, HNF1a coop-
erates with HNF4a in repressing Snail promoter activ-
ity, as measured by luciferase assay (Fig. 2B), and
binds to its identified consensus on human Snail pro-
moter in EMSA (Supporting Fig. 2). Mutation of the
HNF1a binding site abolishes both binding (Support-
ing Fig. 2) and Snail repression without influencing
HNF4a-mediated repression (Fig. 2B). Furthermore,
ChIP experiments revealed that HNF1a binds in vivo
to both murine and human Snail promoters (Fig. 2C).
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Fig. 1. Ectopic HNF4a expression in BW1J cells down-regulates mesenchymal markers and induces transcriptional repression of Snail. (A)
Left: qPCR analysis on BW-H4 cells. Values are expressed as gene expression fold of change versus mock-infected BW1J cells with means 6
SD for triplicate samples (DDCt method; P < 0.05, P < 0.01; Student t test). Right: Western blot analysis of mesenchymal markers vimentin
and a-smooth muscle actin (aSMA) and, as control, tubulin in BW-H4 and BW1J cells. (B) Left: qPCR analysis of endogenous Snail mRNA level
in BW-H4 versus parental BW1J cells. The values are calculated as in (A). P < 0.01. Right: Western blot analysis of Snail, HNF4a, and, as con-
trol, tubulin as in (A). (C) Luciferase assay. Murine wild-type (wt) or mutant (mut) Snail promoter activity measured in BW1J cells transfected
with the indicated amount of the expression vector for HNF4a. Luciferase activity was normalized for cotransfected b-galactosidase activity and
expressed as fold change relative to basal Snail promoter activity (mean 6 SD of three independent experiments performed in triplicate). (D)
EMSA assays with probes designed on the indicated HNF4a consensus binding sites on murine Snail promoter (from "728 to "703 and from
"308 to "283 with respect to the transcriptional start þ1). Nuclear extracts from BW-H4 cells were analyzed for the binding to wild-type (lanes
1-6 in both panels) or mutated (lanes 7-10 in both panels) HNF4a consensus. The specificity of binding was tested by means of anti-HNF4a
(lane 3 of both panels) or unrelated anti-tubulin (lane 4 in both panels) antibodies. Wild-type (wt) and mutant (mut) cold competitor probes
were added in a 200-fold excess (lanes 5, 6 of both panels). (E) qPCR analysis of ChIP assays with anti-HNF4a and anti-NCoR antibodies on
chromatin from MMH-D3 hepatocytes. ChIP on specific HNF4a consensus compared with nonspecific genomic regions (ns) are both normalized
to total chromatin input and expressed as fold enrichment above background (control immunoprecipitation with immunoglobulin G [Ip/IgG]). The
murine Snail promoter consensus sites for HNF4a (H4-1 from "728 to "703 and H4-2 from "308 to "283 with respect to the transcriptional
start þ1) are schematically depicted as black boxes; the regions amplified and the unrelated sequences used as negative control (ns) are
depicted as arrows. Mean 6 SD values from three independent experiments are reported with statistical significance. *P < 0.05.
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Overall, these results demonstrate that direct HNF4a
repression of Snail gene transcription is reinforced by
its target gene HNF1a.
HNF4a and HNF1a Transcriptional Repression
Includes Other EMT Master Genes and Mesenchy-
mal Markers. We extended our analysis to the other
member of the vertebrate Snail family, Slug (Snai2),3
and to HMGA2, a high-mobility group protein
recently proposed to be an inducer of Snail and Slug
gene expression.25 The promoters of these genes have
putative binding sites for both HNF4a and HNF1a.
Ectopic expression of HNF4a and HNF1a in Hep3B
caused a significant decrease of Slug and HMGA2
mRNA levels (Fig. 3A,C). Similar to what was
observed for the Snail gene, this repression activity is
exerted through a direct recruitment of HNFs on
both promoters, as demonstrated by ChIP experiments
(Fig. 3B,D).
Fig. 2. HNF1a cooperates with HNF4a in direct transcriptional repression of Snail gene. (A) qPCR analysis of Snail in parental and HNF1a-
transfected BW1J and Hep3B cells calculated using the DDCt method (P < 0.05). (B) Luciferase assay of Snail promoter activity performed in
BW1J cells transfected with either or both HNF1a and HNF4a expressing constructs. Mutation of the HNF1 consensus was also tested. Luciferase
activities were normalized for b-galactosidase activity and expressed as fold of change (mean 6 SD of three independent experiments). (C)
qPCR analysis of ChIP assay with anti-HNF1a antibody on chromatin derived from parental murine MMH-D3 hepatocytes (left) and human
HNF4a-transfected Hep3B hepatomas (3B-H4) (right). Controls are as described in Fig. 1E. HNF1a consensus sites are depicted as gray boxes
and the amplified region is depicted with black arrows. *P < 0.05.
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Because the promoter analysis of some mesenchymal
genes up-regulated in EMT identified putative HNF4a
and HNF1a binding sites, we extended our ChIP anal-
ysis to fibronectin, vimentin, and desmin. Interestingly,
we found that in MMH-D3 hepatocytes, endogenous
HNFs are recruited to these promoters together with
N-CoR (Fig. 4A). Overall, these results suggest a more
general role for HNFs as direct repressors of the mes-
enchymal differentiation program, through targeting
both EMTmaster and mesenchymal genes.
Epithelial–Mesenchymal–Epithelial Transitions Cor-
relate with Dynamic HNF4a Recruitment to Target
Genes. We have demonstrated that TGFb1 induces
EMT in MMH hepatocytes.7 MMH cells provided a
reliable model to study the reverse process, MET. In
fact, as shown in Fig. 4B-C, TGFb1 withdrawal is
Fig. 3. HNF4a and HNF1a transcriptional repression target other EMT regulators. (A) qPCR analysis of Slug expression in Hep3B cells trans-
fected with the expression vectors for HNF4a (3B-H4) or HNF1(3B-H1) or empty vector as control calculated using the DDCt method (P <
0.05). (B) qPCR analysis of ChIP assays with anti-HNF4a and HNF1a antibodies on chromatin derived from Hep3B cells cotransfected with both
HNF4a and HNF1a constructs. Controls are as described in Fig. 1E. Black and gray boxes indicate the consensus sites for HNF4a (H4-1 and
H4-2) and HNF1a (H1), respectively. Black arrows indicate the region amplified. (C) qPCR analysis of HMGA2 expression in Hep3B cells trans-
fected with the expression vectors for HNF4a (3B-H4) or HNF1a1( 3B-H1) or empty vectors as control calculated using the DDCt method (P <
0.05). (D) qPCR analysis of ChIP assays with anti-HNF4a (left panel) and HNF1a (right panel) antibodies on chromatin derived from Hep3B cells
cotransfected with both HNF4a and HNF1a constructs. Controls are as described in Fig. 1E. Consensus sites for HNF4a (H4-1 and H4-2) and
HNF1a (H1-1 and H1-2) are depicted by black and gray boxes, respectively. PCR-amplified regions are depicted as in B.
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Fig. 4. The epithelial–mesenchymal–epithelial transitions in hepatocytes correlate with dynamic HNF4a binding to target genes. (A) ChIP assay
in MMH hepatocytes showing the endogenous HNF4a and NCoR binding to mouse fibronectin, vimentin, and desmin promoters compared with
unrelated sequences used as negative control (ns). HNFs consensuses are shown in Supporting Fig. 3. *P < 0.05. (B) Evidence of the mutually
exclusive expression of epithelial (occludin [Ocln], E-cadherin [Cdh1]), Snail [Snai1]) and mesenchymal (fibronectin [fn1], metalloproteinase 9
[Mmp9]) markers in MMH-D3 cells treated with TGFb1 as shown by way of semiquantitative reverse-transcription PCR analysis. (C) Phase-con-
trast micrographs and immunofluorescence staining for E-cadherin, ZO-1, and vimentin in MMH-D3 cells treated with TGFb1 for 48 hours
(þTGFb) and 72 hours after cytokine withdrawal (TGFb withdrawal). Scale bar, 40 lm. (D) qPCR analysis of ChIP assay with anti-HNF4a anti-
body on chromatin derived from MMH-D3 hepatocytes treated with TGFb1 for 48 hours (þTGFb) and 72 hours after cytokine withdrawal (TGFb
withdrawal). Controls are as described in Fig. 1E. The HNF4a consensus sites amplified are: "308/"283 for Snai1, "245/"220 for Fibronec-
tin (Fn1), and "226/"201 for E-cadherin. *P < 0.05.
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sufficient to restore the epithelial morphology and
polarity and to revert EMT-regulated gene expression.
We made use of differentiated MMH-D3 hepatocytes
to analyze the endogenous HNF4a recruitment on
chromatin during both EMT and MET. As shown in
Fig. 4D, ChIP experiments highlighted a dynamic
HNF4a binding to the promoters of Snail, fibronectin,
and E-cadherin genes during EMT/METs. These data
demonstrate the presence of endogenous HNF4a on
EMT genes during spontaneous MET, thus implying
its requirement for their negative regulation.
HNF4a Impairment Is Sufficient to Induce Mesen-
chymal Gene Expression in Hepatocytes. As shown
above, overexpression of HNF4a is sufficient to repress
both EMT inducers and mesenchymal markers in dedif-
ferentiated hepatoma cells, whereas in differentiated he-
patocytes the endogenous factor is recruited, together
with corepressors, on promoter regions of the same
genes. These results suggest that the HNF4a-mediated
repression of EMT program could actively contribute to
the maintenance of the hepatocyte phenotype. To test
this hypothesis, we knocked down endogenous HNF4a
expression in MMH cells. When HNF4a was efficiently
silenced at the mRNA and protein levels (Fig. 5A) and
expression of its positively regulated target gene apoC3
(APOC3) (Fig. 5C) decreased, we observed up-regula-
tion of EMT master Snail (Snai1) and Slug (Snai2);
mesenchymal genes vimentin (Vim), desmin (Des), and
N-cadherin (Cdh2); and metalloproteinases Mmp2 and
MMp9 (Fig. 5C). As expected, in depleted cells no occu-
pancy of HNF4a site on Snail promoter was observed
(Fig. 5B). Furthermore, Hnf4a knockdown cells dis-
played, when compared with control cells, down-regula-
tion of the cell polarity marker ZO-1, delocalization of
E-cadherin, increased staining for the mesenchymal
marker desmin (Fig. 5D), and increase in motility as
assessed by migration assays (Fig. 5E).
These results suggest a novel conceptual vision of
the determination of the epithelial identity where
repression of the mesenchymal program is a further
and perhaps equally important function of HNF4a.
Furthermore, the expression of the mesenchymal pro-
gram was investigated in hepatocyte-specific Alb-
Hnf4a"/" knockout mice.14 Figure 6A shows that,
beyond the described hypertrophic phenotype,14 Alb-
Hnf4a"/" hepatocytes exhibit a marked histological
staining to the mesenchymal cytoskeletal proteins des-
min, vimentin, and a-smooth muscle actin. The hepa-
tocyte identity of these cells was also highlighted by
confocal microscopy costaining of albumin and a-
smooth muscle actin. As shown in Supporting Fig. 4,
qPCR analysis of total mRNA preparations from Alb-
Hnf4a"/" liver assessed an up-regulation of mesenchy-
mal markers as well as Snail (Snai1). Moreover,
HNF4a in vivo recruitment on mesenchymal gene
promoters was analyzed via ChIP assay. The enrich-
ment for the promoter amplicons was approximately
seven- to eight-fold for fibronectin and nearly two-fold
for snail (Fig. 6B). Overall, these data demonstrate
that HNF4a is required for both the maintenance of
hepatic epithelial differentiation and induction of
MET, through the up-regulation of epithelial gene
expression and direct down-regulation of EMT genes.
Discussion
The orphan nuclear receptor HNF4a has long been
considered a key factor in hepatocyte differentia-
tion.26,27 Evidence for its pivotal role in controlling
the hepatic phenotype arises from a number of obser-
vations: (1) it controls the development of the hepatic
epithelium and liver morphogenesis,11 (2) it triggers
epithelial polarization of embryonic cells,28 and (3) it
re-establishes the epitheliality in dedifferentiated hepa-
tomas.16 Recent integrated approaches have extended
its putative biological function to a broad repertoire of
target genes that participate in other cellular functional
categories (cell cycle, apoptosis, stress response, and
cancer).29 The majority, if not all, of these observa-
tions assigns to HNF4a a positive role in the regula-
tion of gene expression.
The main finding of our work is to ascribe to
HNF4a a novel general ‘‘anti-mesenchymal’’ role
through the orchestrated repression of both master
EMT regulators and mesenchymal genes. We provided
evidence for the repression of the mesenchymal gene
program executed not only during an HNF4a-medi-
ated MET process induced in undifferentiated hepato-
carcinoma cells but also in the normal fully differenti-
ated hepatocytes that stably retain the epithelial
phenotype. In dedifferentiated hepatomas, ectopic
HNF4a was sufficient to down-regulate Snail, Slug,
HMGA2, vimentin, and fibronectin expression. In dif-
ferentiated hepatocytes, endogenous HNF4a was
found stably recruited to the promoters of EMT
inducers and mesenchymal genes. Interestingly, Snail,
HMGA2, and vimentin were classified as putative
HNF4a targets by way of an in silico search.29 Our
ChIP data provide functional evidence for this predic-
tion, thus indicating that HNF4a-mediated induction
of the epithelial phenotype is linked to its repression
of EMT genes. The interpretation of an HNF4a con-
stitutive repressive role of the mesenchymality is
enforced by NCoR recruitment to HNF4a regulatory
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regions in the promoters of Snail and several mesen-
chymal genes.
In addition, knockdown of HNF4a provides further
evidence for its direct repression of mesenchymal tar-
gets. Using both cell culture and liver-specific Hnf4a
knockout mouse models, we demonstrate a direct cor-
relation between loss of Hnf4a and up-regulation of
the mesenchymal genes. Histological examination of
liver sections from Alb-Hnf4a"/" mice showed that
hepatocytes with the known hypertrophic phenotype
express vimentin, desmin, fibronectin, and a-smooth
muscle actin and this with no noted increase in non-
parenchymal cells.14
Although the cell culture model suggests a more
dramatic influence of HNF4a loss on the transition to
mesenchymality, within the context of the whole
Fig. 5. HNF4a knockdown promotes acquisition of mesenchymal features in hepatocytes. (A) Right: qPCR analysis showing the fold change in
HNF4a mRNA levels in control and HNF4a siRNA–transfected MMH-D3 cells calculated using the DDCt method (P < 0.05). Left: Western blot
analysis of HNF4a protein levels in the same cells. (B) qPCR analysis of ChIP assay performed as described in Fig. 1E in siHNF4a MMH-D3
cells. *P < 0.05. (C) qPCR analysis of the indicated genes in control siRNA and HNF4a siRNA transfected MMH-D3 cells calculated using the
DDCt method. *P < 0.05, **P < 0.01 (Student t test). (D) Immunofluorescence staining for the indicated proteins in control siRNA and
HNF4a siRNA transfected MMH-D3 cells. Scale bar, 40 lm. (E) Left: Quantitation of migrating MMH-D3 cells transfected with control and HNF4a
siRNA in scratch assays performed for the indicated times. Data represent the mean cell counts per field in two independent experiments. Right:
Representative phase micrographs of the same assays. Scale bar, 80 microns.
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animal, Hnf4a depletion results in only a partial tran-
sition to the mesenchymal phenotype. In particular,
while comparable quantification of in vivo HNF4a
recruitment was found between whole liver and MMH
cells for the fibronectin promoter, enrichment was not
as consistent for the Snail promoter. This may be a
reflection of epigenetic differences between cell lines
and in vivo hepatocytes. After embryonic development,
it is conceivable that the Snail promoter is hyperme-
thylated in the adult hepatocyte to maintain differen-
tiation. If this occurs, it might interfere with Hnf4a
binding and thus explain the weak enrichment for
HNF4a on the Snail promoter in the in vivo ChIP
assay. In line with this hypothesis is the observation
that the Snail promoter CpG island is hypermethy-
lated in the early stages of a mouse skin tumorigenesis
Fig. 6. HNF4a knockout mice express mesenchymal genes. (A) Left: Immunohistochemical analysis of liver samples from wild-type (F/F) and
Hnf4a knockout (-/-) mice for the indicated mesenchymal markers. Right: Confocal microscopy analysis of two representative liver samples from
the same mice showing the costaining of albumin and a-smooth muscle actin (aSMA (white arrows)). (B) qPCR analysis of ChIP assay performed
with total liver tissue extracts (n ¼ 2) showing HNF4a recruitment on FXIIIB used as positive control on fibronectin (Fn1) and on Snail ("728/
"703) promoters. Mean 6 SD of promoter sequence amplification compared with nonspecific (ns) region are reported with P values (P <
0.005, P < 0.02).
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model but is demethylated at a later, metastatic stage
coincident with the repression of E-cadherin
expression.30
Previously, we demonstrated that Snail represses Hnf4a
transcription through direct promoter binding.6 We pro-
pose a simple cross-regulatory circuit between Snail and
HNF4a in which the expression of each factor is mutually
exclusive to the other due to the presence of repressor ele-
ments in each promoter. HNF4a/Snail reciprocal control
may provide the molecular rationale for feedback and re-
versible differentiative processes and explain, at least in
part, the coherence and the reversibility of the molecular
events underlying EMT/MET. In our cellular model,
TGFb induces EMT through Snail-dependent and Snail-
independent mechanisms.6,7 Although further efforts are
required to clarify this process, our preliminary evidence
suggests that this includes HNF4a functional inactivation.
Notably, we provide evidence extending an antime-
senchymal role to HNF1a, another important liver-
enriched transcription factor. HNF1a is positively
regulated by HNF4a and was recently proposed to
have transcriptional repressor function on genes poten-
tially involved in hepatocyte tumorigenesis.31 Our
findings indicate that HNF4a and HNF1a transcrip-
tional repression of critical mesenchymal genes is piv-
otal for the maintenance of a stable epithelial pheno-
type as well as for the regulation of the dynamic
process of MET. In conclusion, our data integrate the
well-established notion of the pivotal positive role of
HNF4a in hepatocyte differentiation through expres-
sion of epithelial genes with the new concept of active
repression of mesenchymal genes.
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